CEFTRIAXONE FOR INJECTION
FRESENIUS KABI CANADA LTD
Quick answers
Is there a shortage of CEFTRIAXONE FOR INJECTION in Canada?
No. There is no current shortage of CEFTRIAXONE FOR INJECTION 1G reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
ROCEPHIN PWS 1GM/VIAL
HOFFMANN-LA ROCHE LIMITED
ROCEPHIN PWS INJ 1GM/VIAL
HOFFMANN-LA ROCHE LIMITED
Other Products
ROCEPHIN PWS 2GM/VIAL
HOFFMANN-LA ROCHE LIMITED
ROCEPHIN PWS INJ 0.25GM/VIAL
HOFFMANN-LA ROCHE LIMITED
ROCEPHIN INJ 10GM/VIAL
HOFFMANN-LA ROCHE LIMITED
SANDOZ CEFTRIAXONE
SANDOZ CANADA INCORPORATED
DIN
02289695
Strength
1G
Dosage Form
Powder For Solution
Route
Intravenous Intramuscular
Active Ingredient
CEFTRIAXONE (CEFTRIAXONE SODIUM)
See all CEFTRIAXONE (CEFTRIAXONE SODIUM) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from FRESENIUS KABI CANADA LTD
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
900MG · DIN 02395150
20MG · DIN 02538644
50MG · DIN 02403536
50MG · DIN 02236926
DIN 02497697
3MG · DIN 02457482
3MG · DIN 02267659
3MG · DIN 02457474
50MG · DIN 02245248
250MG · DIN 02227029
2G · DIN 02226995
1G · DIN 02227002